Note 17 - Segment and Geographic Information

9 Months Ended

Feb. 29, 2016

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

17. SEGMENT AND GEOGRAPHIC INFORMATION

The Company determines operating segments in accordance with its internal operating structure, which is organized based upon product groups. Each segment is separately managed and is evaluated primarily upon operating results.

The Company has two operating segments, the Transfusion segment and the Transplant & Molecular segment, which have been aggregated into one reportable segment.

The Company manufactures and markets a complete line of diagnostics products and automated systems used primarily by hospitals, donor centers and reference laboratories in a number of tests performed to detect and identify certain properties of human blood and human tissue to enable the most compatible match available between patient and donor. These tests are performed for the purpose of blood transfusion and transplant.

The Company operates in various geographic markets. These geographic markets are comprised of the United States, Europe, Canada and other international markets. The majority of the other international markets are considered Emerging Markets for our business. Our products are marketed globally, both directly to the end user and through established distributors.

Accounting policies for segments are the same as those described in the summary of significant accounting policies.

The following is a summary of the Company’s segment data (in thousands):

	Three Months Ended				Nine Months Ended
	February 29		February 28		February 29		February 28
	2016		2015		2016		2015
Net sales by product group:
Transfusion	$	73,589		79,929		235,296		247,950
Transplant & Molecular		15,304		15,676		46,558		46,373
Total	$	88,893		95,605		281,854		294,323

Following is a summary of enterprise-wide information (in thousands):

	Three Months Ended				Nine Months Ended
	February 29		February 28		February 29		February 28
	2016		2015		2016		2015
Net sales to customers by geography are as follows:
United States	$	57,435		60,205		179,878		179,679
Europe (A)		16,609		18,313		52,517		59,882
Canada		3,233		4,598		11,084		14,200
Other		11,616		12,489		38,375		40,562
Total	$	88,893		95,605		281,854		294,323

Net sales are attributed to individual countries based on the customer’s country of origin at the time of the sale and where the Company has an operating entity.

	As of
	February 29, 2016		May 31, 2015
Long-lived assets (excluding goodwill and intangibles) by geography:
United States	$	52,806		52,764
Europe (B)		14,059		14,542
Canada		3,483		4,029
Other (C)		2,440		2,239
Total	$	72,788		73,574

	As of
	February 29, 2016		May 31, 2015
Concentration of net assets by geography:
United States	$	218,636		241,522
Europe		99,135		100,071
Canada		26,274		30,274
Other (C)		12,577		11,814
Total	$	356,622		383,681

(A) - Net sales to any individual country within Europe were not material to the Company’s consolidated net sales.

(B) - Long-lived assets located in any individual country within Europe were not material to the Company's

consolidated long-lived assets.

(C) - Primarily Japan and India.

Sales to any individual customer did not equal or exceed 10% of our net sales during the three months and nine months ended February 29, 2016, or during the three months and nine months ended February 28, 2015.